A new biotechnology company in Chile: PerOs Aquatic
Oralject(TM) is a technology that permits the oral delivery of a variety of therapeutic molecules, including antigens, peptides and nutraceuticals. Oralject(TM) can be combined with these prescribed bioactive compounds and administered at virtually any stage of a fish's growth cycle. This unique drug delivery technology will allow PerOs Aquatic to offer unprecedented protection to fish crops. Unlike injectable drug delivery methods, PerOs' Oralject(TM) technology allows fish to be protected in any field situation.
Over the next few years, PerOs Aquatic will be introducing a range of new Oralject(TM) technology applications, and Chile will be the first country in the world to have access to these solutions.
PerOs Aquatic's veterinary specialists will work directly with Chilean fish producers to evaluate health problems encountered at their installations and develop customized treatments that take advantage of the flexibility of PerOs' Oralject(TM) technology. Based on these cooperative ventures, PerOs Aquatic will continue to develop and manufacture Oralject(TM) applications that will impact the aquaculture industry throughout the world.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.